MARLBOROUGH, Mass.,
Nov. 6, 2018 /PRNewswire/ -- RXi
Pharmaceuticals Corporation (NASDAQ: RXII) a biotechnology company
developing the next generation of immuno-oncology therapeutics
based on its proprietary self-delivering RNAi (sd-rxRNA®)
therapeutic platform today announced that it will report its
financial results for the third quarter ended September 30, 2018, and provide a business update
on Wednesday, November 14, 2018 after
the close of the U.S. financial markets.
Logo -
http://mma.prnewswire.com/media/594748/RXi_Pharmaceuticals_Corporation_Logo.jpg
A live audio webcast will begin at 4:30
p.m. EDT. The webcast link is available under the "Investors
– Events and Presentations" section of the Company's website,
www.rxipharma.com. The event may also be accessed by dialing
toll-free in the United States: +1
844-376-4678. International participants may access the event by
dialing: +1 209-905-5958.
An archive of the webcast will be available on the Company's
website approximately two hours after the presentation.
About RXi Pharmaceuticals
RXi Pharmaceuticals Corporation (NASDAQ: RXII) is a
biotechnology company developing the next generation of
immuno-oncology therapeutics based on its self-delivering RNAi
(sd-rxRNA®) therapeutic platform. The Company's discovery and
research efforts are focused on developing sd-rxRNA therapeutic
compounds to be used in the context of adoptive cell transfer by
targeting checkpoints or other gene targets, or to be used as
intratumoral immunotherapy. We aim to maximize the power of our
sd-rxRNA therapeutic compounds by weaponizing therapeutic immune
effector cells to attack cancer, and to make tumors more
susceptible to such attacks, and ultimately provide patients
battling cancers with a powerful new treatment option that goes
beyond current treatment modalities. RXi intends to develop
immuno-oncology therapeutics on our own and in collaboration with
partners. For additional information, visit the Company's
website, www.rxipharma.com.
Contact
RXi Pharmaceuticals Corporation
ir@rxipharma.com
View original
content:http://www.prnewswire.com/news-releases/rxi-pharmaceuticals-to-webcast-third-quarter-2018-financial-results-on-wednesday-november-14-2018-300744344.html
SOURCE RXi Pharmaceuticals Corporation